This story only skimmed the surface of questions we think should have been raised for any claims made about trial results presented in this way for a drug promoted as a sexual desire booster. ...

Story doesn’t explain the evidence behind the guidelines. Readers learn of the guideline controversy but get little information to help them evaluate their credibility, applicability or relevance....

Well-organized story that could have been improved by noting the limitations of drawing conclusions from scientific meeting talks, and by comparing radiation risks of the two approaches studied....

An all-too unquestioning story about a new drug, flibanserin, being touted by some as “female Viagra.” Incomplete discussion of the limited evidence and of disease-mongering....

This story doesn’t discuss what readers reasonably want to know: what the guidelines are based on, how they might apply to them, and what the risks of getting the screening--or not getting it--are....

This story did some things that longer stories didn’t. But it didn’t include viewpoints from any independent sources. So it distilled the new guidelines on the readers' behalf. But not much more....

This story had one major flaw – suggesting that this was about withholding needed care – a misguided suggestion that overshadowed the task force’s call for improved shared decision-making....

Overall good job. However, the story may give readers an exaggerated sense of the value of this device in several ways that we explain in detail in our review....

This story, on a novel approach to infusing chemotherapy for a brain tumor, just goes to show what a careful, engaged reporter can accomplish when given sufficient time and space to write a story....

The story provides a reasonable amount of information on the study and places it in context of other studies and in context of other treatment options....

Another well-done "Healthy Skeptic" column - this one about on-the-skin diet patches, their claims, and the lack of published evidence to back up those claims....